{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T06:16:03Z","timestamp":1673504163745},"reference-count":14,"publisher":"Japan Endocrine Society","issue":"Suppl.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.64.s41","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:22:42Z","timestamp":1498256562000},"page":"S41-S46","source":"Crossref","is-referenced-by-count":3,"title":["Ghrelin does not influence cancer progression in a lung adenocarcinoma cell line"],"prefix":"10.1507","volume":"64","author":[{"given":"Hironobu","family":"Tsubouchi","sequence":"first","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Onomura","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehisa","family":"Yanagi","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan"},{"name":"Research director of CREST, Japan Agency for Medical Research and Development (AMED)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. <i>Cell Metab<\/i> 16: 153-166.","DOI":"10.1016\/j.cmet.2012.06.011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, <i>et al<\/i>. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. <i>Nature<\/i> 402: 656-660.","DOI":"10.1038\/45230"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Akamizu T, Kangawa K (2011) Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect. <i>Peptides<\/i> 32: 2295-2300.","DOI":"10.1016\/j.peptides.2011.05.018"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chopin LK, Seim I, Walpole CM, Herington AC (2012) The ghrelin axis--does it have an appetite for cancer progression? <i>Endocr Rev<\/i> 33: 849-891.","DOI":"10.1210\/er.2011-1007"},{"key":"5","unstructured":"5. Lin TC, Hsiao M (2017) Ghrelin and cancer progression. <i>Biochim Biophys Acta<\/i> 1868: 51-57."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tisdale MJ (2002) Cachexia in cancer patients. <i>Nat Rev Cancer<\/i> 2: 862-871.","DOI":"10.1038\/nrc927"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Matsubara D, Ishikawa S, Oguni S, Aburatani H, Fukayama M, <i>et al<\/i>. (2010) Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells. <i>J Thorac Oncol<\/i> 5: 1317-1324.","DOI":"10.1097\/JTO.0b013e3181e2a409"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, <i>et al<\/i>. (2011) High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. <i>PLoS One<\/i> 6: e21746.","DOI":"10.1371\/journal.pone.0021746"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lien GS, Lin CH, Yang YL, Wu MS, Chen BC (2016) Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways. <i>Eur J Pharmacol<\/i> 776: 124-131.","DOI":"10.1016\/j.ejphar.2016.02.044"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tian PY, Fan XM (2012) The proliferative effects of ghrelin on human gastric cancer AGS cells. <i>J Dig Dis<\/i> 13: 453-458.","DOI":"10.1111\/j.1751-2980.2012.00616.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mao Y, Wang J, Yu F, Li Z, Li H, <i>et al<\/i>. (2016) Ghrelin protects against palmitic acid or lipopolysaccharide-induced hepatocyte apoptosis through inhibition of MAPKs\/iNOS and restoration of Akt\/eNOS pathways. <i>Biomed Pharmacother<\/i> 84: 305-313.","DOI":"10.1016\/j.biopha.2016.09.043"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhang Q, Huang WD, Lv XY, Yang YM (2011) Ghrelin protects H9c2 cells from hydrogen peroxide-induced apoptosis through NF-kappaB and mitochondria-mediated signaling. <i>Eur J Pharmacol<\/i> 654: 142-149.","DOI":"10.1016\/j.ejphar.2010.12.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zong WX, Rabinowitz JD, White E (2016) Mitochondria and Cancer. <i>Mol Cell<\/i> 61: 667-676.","DOI":"10.1016\/j.molcel.2016.02.011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, <i>et al<\/i>. (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. <i>Proc Natl Acad Sci U S A<\/i> 107: 8788-8793.","DOI":"10.1073\/pnas.1003428107"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/Suppl.\/64_64.S41\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T22:37:55Z","timestamp":1569537475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/Suppl.\/64_64.S41\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"journal-issue":{"issue":"Suppl.","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.64.s41","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}